Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108003141A reveals a safer alfuzosin route. Achieve cost reduction in pharmaceutical intermediates manufacturing with stable yields and scalable processes.
Advanced synthesis of Propacetamol Hydrochloride via patent CN114907226B. Delivers high purity, reduced solvent use, and scalable manufacturing for global supply chains.
Patent CN120554281A reveals a safer synthesis route for HALS intermediates. Achieve cost reduction and supply chain reliability with this novel atmospheric pressure method.
Patent CN114349648A details a one-step ruthenium-catalyzed reductive amination for high-purity chiral amines, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103224963B reveals marine strain catalysis for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN101104609B discloses a mild reductive amination route for Solanesyl polyamine derivatives, offering high yields and scalable production for oncology drug discovery.
Novel copper-catalyzed Bunte salt thioamination for high-purity maleimide intermediates. Reduces odor and cost in pharma manufacturing.
Novel non-hydrogenation route for Tamsulosin HCl. Eliminates heavy metals in step 1, ensuring high purity and safety for API manufacturing.
Patent CN112624895A reveals a green route for 3,4,5-trifluorobromobenzene. Reduces waste and cost for agrochemical and electronic chemical manufacturing supply chains.
Novel S1P1 modulator synthesis via Mitsunobu reaction. Mild conditions, high selectivity. Reliable pharmaceutical intermediates supplier for IPF drug development.
Novel four-step synthesis route offers high purity and reduced energy consumption for reliable pharmaceutical intermediate supply chain optimization and cost reduction in manufacturing processes globally.
Novel synthesis of nitrogenous calix[4]arene derivatives via Ullmann amination. Offers mild conditions and scalable production for specialty chemical applications.
Patent CN103276025A details a high-purity enzymatic route for L-heterocyclic amino acids, offering significant cost and supply chain advantages for API manufacturing.
Patent CN104945345A details low-cost benzoin route for chiral morpholine synthesis offering significant supply chain stability and cost advantages for global buyers.
Novel reductive amination process for sitagliptin intermediates eliminates precious metals, enhancing purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN101654416A details a scalable synthesis for anticancer intermediates, offering improved yields and safer processing compared to traditional nitro-reduction methods.
Patent CN110577941B reveals mutated enzymes for high-purity chiral amine synthesis, offering cost reduction in pharmaceutical intermediate manufacturing via biocatalysis.
Patent CN109134267B discloses a metal-free route to aromatic amines from alkyl aromatics. Offers significant cost reduction and scalability for API manufacturing.
Discover the metal-free synthesis of aromatic amines via patent CN109134267A. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.